{"id":"NCT02748057","sponsor":"Organon and Co","briefTitle":"A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-833)","officialTitle":"A Phase III, Open-label, Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653H in Japanese Patients With Hypercholesterolemia Who Have Inadequate LDL-C Control on Ezetimibe or Rosuvastatin Monotherapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-05-18","primaryCompletion":"2017-12-11","completion":"2017-12-11","firstPosted":"2016-04-22","resultsPosted":"2018-12-04","lastUpdate":"2024-05-16"},"enrollment":135,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hypercholesterolemia","Familial Hypercholesterolemia"],"interventions":[{"type":"DRUG","name":"Ezetimibe","otherNames":[]},{"type":"DRUG","name":"Rosuvastatin","otherNames":[]}],"arms":[{"label":"Ezetimibe 10 mg + Rosuvastatin 2.5 mg","type":"EXPERIMENTAL"},{"label":"Ezetimibe 10 mg + Rosuvastatin 5.0 mg","type":"EXPERIMENTAL"}],"summary":"The study will assess the safety and tolerability of Ezetimibe 10 mg+ Rosuvastatin 2.5 mg and Ezetimibe 10 mg+ Rosuvastatin 5.0 mg for up to 52 weeks in Japanese participants with hypercholesterolemia uncontrolled with monotherapy of Ezetimibe 10 mg or Rosuvastatin up to 5 mg.","primaryOutcome":{"measure":"Percentage of Participants Who Experience at Least 1 Adverse Event (AE)","timeFrame":"Up to 2 weeks post last dose of study drug (up to 54 weeks)","effectByArm":[{"arm":"Ezetimibe 10 mg + Rosuvastatin 2.5 mg","deltaMin":72.8,"sd":null},{"arm":"Ezetimibe 10 mg + Rosuvastatin 5.0 mg","deltaMin":76.2,"sd":null}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":15},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":114},"commonTop":["Nasopharyngitis","Back pain","Gastroenteritis","Liver function test abnormal","Type 2 diabetes mellitus"]}}